
Alopecia Areata Might Be Tied to Higher Long-Term Glaucoma Risk
Key Takeaways
- EHR-derived cohorts showed higher glaucoma risk with alopecia areata (15-year HR 1.89), with signal present at 5 years and increasing through 10 years.
- Robustness checks using psoriasis as an active comparator and excluding “glaucoma suspect” codes preserved the association, and a separate US network validated it (HR 2.11).
A TriNetX retrospective cohort found adults with alopecia areata—especially women—face a nearly doubled glaucoma risk, with implications for ophthalmology and comorbidities.
Adults with
Long-Term Eye Risk in Alopecia Areata Had Never Been Characterized
More than 2.7 million Americans older than 40 years have
The researchers used the TriNetX Global Collaborative Network, which draws on electronic health records from 147 health care organizations and more than 144 million patients, then validated key findings in a separate US-only network. Adults with at least 2 visits and a diagnosis of alopecia areata between 2005 and 2023 were matched 1:1 by propensity score to patients who had a general health exam, balancing age, sex, race, body mass index, and conditions including hypertension, diabetes, conjunctivitis, iridocyclitis, and Sjögren syndrome.1
After matching, the analysis compared 28,966 patients with alopecia areata with 28,966 matched controls. The alopecia areata cohort was 57.8% female with a mean age of 33.0 years before matching, and new-onset glaucoma was identified using administrative diagnosis codes rather than direct eye examination.
Risk Climbed With Age and Was Significant Only in Women
Over 15 years of follow-up, patients with alopecia areata had a significantly higher risk of developing glaucoma than matched controls (HR, 1.89; 95% CI, 1.51-2.38), with the risk evident at 5 years (HR, 1.57; 95% CI, 1.23-2.00) and rising further by 10 years (HR, 1.98; 95% CI, 1.59-2.46). The association held up when psoriasis served as an active comparator instead of a general health exam (HR, 1.74; 95% CI, 1.43-2.12) and when the researchers excluded diagnosis codes for glaucoma suspects (HR, 1.68; 95% CI, 1.01-2.78), and it was confirmed in the separate US validation network (HR, 2.11; 95% CI, 1.72-2.59).
The risk was concentrated in certain subgroups: it was significant in women (HR, 1.78; 95% CI, 1.36-2.33) but not in men (HR, 1.30; 95% CI, 0.90-1.87), and it was higher in patients 65 years and older (HR, 2.76; 95% CI, 1.95-3.89) than in those 18 to 64 years (HR, 1.87; 95% CI, 1.44-2.42).
“[This study] establishes an epidemiologic association only and does not demonstrate a direct biological or immune-mediated link,” the researchers wrote.
Administrative Coding and Limited Diversity Temper the Findings
Because glaucoma was identified through diagnosis codes rather than intraocular pressure measurements, optical coherence tomography, visual field testing, or specialist confirmation, some misclassification is possible, and the researchers could not fully account for corticosteroid use or other residual confounders. Surveillance bias is also a concern: patients already engaged with health care, particularly for suspected glaucoma, may simply be more likely to receive a diagnosis.
The study population was drawn mostly from North American and European sites and was predominantly White or Black, with few Asian patients, and the analysis included only adults, so the findings may not generalize to children or to more racially and ethnically diverse populations. The researchers also lacked data on alopecia areata severity, which could influence risk.
The findings add glaucoma to the list of comorbidities worth discussing with patients who have alopecia areata, particularly women and patients 65 years and older, even though the study cannot say whether the disease itself, its treatments, or shared underlying risk factors are responsible. The case for any formal vision-screening pathway tied to an alopecia areata diagnosis remains unproven; the researchers' own framing argues for further mechanistic study rather than for treating this association as settled.
References
- Chang HC, Lai VP, Su YJ, Chen SJ, Wu MC, Gau SY. Alopecia areata patients are associated with increased risk of glaucoma: a multicenter, retrospective cohort study. Front Immunol. 2026;17:1870857. doi:10.3389/fimmu.2026.1870857
- 10 things you should know about glaucoma. National Eye Institute, National Eye Health Education Program, National Institutes of Health. Updated January 6, 2017. Accessed October 12, 2026.
https://www.nei.nih.gov/about/news-and-events/news/10-things-you-should-know-about-glaucoma
Related to this article








